Alistair Macdonald insider trades: Syneos Health (SYNH) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Alistair reports to the SEC
Open-market buys and sales
23 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 3, 2021 | SYNH | ↓ Sell10b5-1 | 40,263 | $88.19 | $3.6M | Direct | Aug 4, 2021 (1d) |
| Jun 1, 2021 | SYNH | ↓ Sell10b5-1 | 4,889 | $88.20 | $431K | Direct | Jun 3, 2021 (2d) |
| Apr 9, 2021 | SYNH | ↓ Sell10b5-1 | 14,039 | $80.00 | $1.1M | Direct | Apr 12, 2021 (3d) |
| Apr 1, 2021 | SYNH | ↓ Sell10b5-1 | 17,398 | $77.61 | $1.4M | Direct | Apr 5, 2021 (4d) |
| Feb 2, 2021 | SYNH | ↓ Sell10b5-1 | 64,497 | $75.71 | $4.9M | Direct | Feb 3, 2021 (1d) |
| Dec 23, 2020 | SYNH | ↓ Sell10b5-1 | 1,500 | $70.12 | $105K | Direct | Dec 28, 2020 (5d) |
| Aug 3, 2020 | SYNH | ↓ Sell | 10,289 | $65.07 | $669K | Direct | Aug 4, 2020 (1d) |
| Jul 15, 2020 | SYNH | ↓ Sell | 28,401 | $60.14 | $1.7M | Direct | Jul 17, 2020 (2d) |
| Jul 14, 2020 | SYNH | ↓ Sell | 8,828 | $58.48 | $516K | Direct | Jul 15, 2020 (1d) |
| Feb 13, 2019 | SYNH | ↓ Sell | 8,143 | $53.00 | $432K | Direct | Feb 15, 2019 (2d) |
| Feb 5, 2019 | SYNH | ↓ Sell | 6,697 | $53.04 | $355K | Direct | Feb 7, 2019 (2d) |
| Sep 18, 2017 | INCR | ↓ Sell | 2,348 | $54.60 | $128K | Direct | Sep 19, 2017 (1d) |
| Aug 17, 2017 | INCR | ↓ Sell | 8,828 | $55.65 | $491K | Direct | Aug 21, 2017 (4d) |
| Jul 3, 2017 | INCR | ↓ Sell | 10,555 | $58.38 | $616K | Direct | Jul 5, 2017 (2d) |
| May 1, 2017 | INCR | ↓ Sell | 9,467 | $45.00 | $426K | Direct | May 2, 2017 (1d) |
| Mar 3, 2017 | INCR | ↓ Sell | 8,828 | $45.00 | $397K | Direct | Mar 6, 2017 (3d) |
| Jan 20, 2017 | INCR | ↓ Sell | 1,375 | $50.50 | $69K | Direct | Jan 23, 2017 (3d) |
| Jan 5, 2017 | INCR | ↓ Sell | 14,840 | $52.19 | $774K | Direct | Jan 6, 2017 (1d) |
| Aug 17, 2016 | INCR | ↓ Sell | 8,828 | $43.80 | $387K | Direct | Aug 18, 2016 (1d) |
| Jul 11, 2016 | INCR | ↓ Sell | 9,468 | $40.19 | $380K | Direct | Jul 12, 2016 (1d) |
| Dec 31, 2015 | INCR | ↓ Sell | 159,599 | $47.46 | $7.6M | Direct | Jan 4, 2016 (4d) |
| Dec 7, 2015 | INCR | ↓ Sell | 42,959 | $44.63 | $1.9M | Direct | Dec 9, 2015 (2d) |
| Sep 28, 2015 | INCR | ↓ Sell | 44,522 | $39.93 | $1.8M | Direct | Sep 29, 2015 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Alistair Macdonald's insider trades
Alistair Macdonald is Chief Executive Officer at Syneos Health (SYNH). Since Sep 28, 2015, Alistair has reported no open-market purchases and 23 sales worth $30.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
6 sales (38% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include shares withheld for taxes (23 filings), option exercises (20 filings), grants and awards (13 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SYNH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.